Fifth Third Bancorp Has $19.98 Million Stock Position in Cigna Group $CI

Posted by Brenda Bartman on Aug 16th, 2026

Fifth Third Bancorp lessened its stake in shares of Cigna Group (NYSE:CI – Free Report) by 5.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 72,463 shares of the health services provider’s stock after selling 4,197 shares during the period. Fifth Third Bancorp’s holdings in Cigna Group were worth $19,977,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of CI. Wilkerson Advisory Group LLC acquired a new stake in shares of Cigna Group during the fourth quarter valued at approximately $25,000. Cedar Mountain Advisors LLC grew its position in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares in the last quarter. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group during the 4th quarter valued at $29,000. Prosperity Bancshares Inc purchased a new stake in shares of Cigna Group in the fourth quarter valued at $29,000. Finally, Creative Financial Designs Inc. ADV boosted its position in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after buying an additional 81 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Cigna Group Stock Performance

Shares of NYSE CI opened at $282.24 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The business’s 50-day moving average price is $286.02 and its two-hundred day moving average price is $281.28. The company has a market capitalization of $74.58 billion, a P/E ratio of 11.68, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the business earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on CI shares. Wolfe Research reissued an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Royal Bank Of Canada increased their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research report on Friday, July 31st. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Finally, Guggenheim increased their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Get Our Latest Report on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.